Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
POS1046 DEUCRAVACITINIB LONG-TERM EFFICACY AND SAFETY IN PLAQUE PSORIASIS: 2-YEAR RESULTS FROM THE PHASE 3 POETYK PSO PROGRAM
2022
12 citations
Journal Article
bronze Open Access
Field-Weighted Citation Impact:
0.85
POS1046 DEUCRAVACITINIB LONG-TERM EFFICACY AND SAFETY IN PLAQUE PSORIASIS: 2-YEAR RESULTS FROM THE PHASE 3 POETYK PSO PROGRAM | Researchclopedia
Bristol-Myers Squibb (United States)
J. Toms
·
Bristol-Myers Squibb (United States)
A. Buck
·
Bristol-Myers Squibb (United States)
S. Banerjee
·
Bristol-Myers Squibb (United States)
A. Menter
·
Baylor University Medical Center